drugset
drugset / Trial / NCT01394445

Pilot Study of Physostigmine-Enhanced Opioid Analgesia

NCT01394445 ↗

Phase 3 Completed 20 enrolled Medical University of Graz
RandomizedSingle-groupTriple-blindTreatment

Summary

The investigators hypothesize that the administration of physostigmine in the postoperative period after nephrectomy reduces opioid consumption.

Timeline

Start
2011-06
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Physostigmine Small molecule 1 mg Intravenous

Indications

No indication recorded.